Using AI to improve prostate cancer diagnosis and prognosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the use of multimodal artificial intelligence systems to enhance the accuracy of prostate cancer diagnosis and prognosis. By integrating various data types, including imaging, genomics, pathology, and clinical information, the research aims to facilitate precision medicine approaches for prostate cancer. The study leverages advanced AI techniques, such as deep learning and machine learning, to analyze extensive medical datasets, ultimately aiming to improve treatment outcomes and survival rates for patients. Participants will include men with normal prostate conditions, benign prostatic hyperplasia, or prostate cancer who have undergone relevant imaging examinations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male, 18-80 years of age;
2. Patients with normal prostate, prostatic hyperplasia, or prostate cancer who have undergone a prostate or pelvic magnetic resonance (MR) examination;
3. First visit on January 1, 2014 or later.

Exclusion Criteria:

1. Patients with a diagnosis of any other malignancy within the previous 5 years;
2. Patients who have undergone transurethral resection or enucleation of the prostate prior to undergoing imaging;
3. Patients who are not suitable for participation in this clinical trial in the judgment of the investigator;

Patients who meet any of the above criteria may not be enrolled as subjects.

Where it's running

• Shanghai Changzheng Hospital
  Shanghai, Shanghai, China Recruiting

Study contacts

• Study coordinator: Shancheng Ren, MD,PhD
• Email: renshancheng@gmail.com
• Phone: 8613917793885

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

• MRI-DTI look at the urethral sphincter ring and prostate base shape

  This imaging study tests how the male urethral internal sphincter ring appears on MRI-DTI and how it relates to prostate base morphology in men undergoing clinically indicated MRI.

  Recruiting Jiangsu Taizhou People's Hospital · Taizhou, Jiangsu · NCT07694752

• Bioblation: Combined biopsy and laser treatment for prostate symptoms and suspected cancer

  A single-session procedure (Bioblation) combines a trans-perineal prostate biopsy with laser ablation to relieve severe LUTS and treat likely low- to favorable intermediate-risk prostate cancer.

  Recruiting Benha University · Banhā, Qalyubia Governorate · NCT07526675

• Treatment for male overactive bladder using sacral neuromodulation

  This study is testing a new device to see if it can help men with overactive bladder feel better after prostate surgery or radiation therapy.

  Recruiting at 21 sites Axonics, Inc. · Birmingham, Alabama and 22 other locations · NCT06511141

• Registry for patients undergoing TULSA procedure for prostate conditions

  This study is tracking patients who have had the TULSA procedure for prostate issues to see how safe and effective it is and how it affects their quality of life over time.

  Recruiting at 5 sites Profound Medical Inc. · West Hills, California and 4 other locations · NCT05001477

• Targeted alpha therapy for B7-H3 expressing solid tumors using AKY-2519

  This phase 1b trial tests a radiolabeled drug (AKY-2519) to see if it's safe and tolerable in adults with B7-H3 positive advanced solid tumors, including NSCLC and SCLC, with imaging to help guide use.

  Recruiting at 2 sites Phase 1 Aktis Oncology, Inc. · Miami, Florida and 1 other locations · NCT07887971

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.